Search results
Results From The WOW.Com Content Network
Foundation Medicine was founded in Cambridge, Massachusetts. [3] The company was conceived after Broad Institute researchers Levi Garraway and Matthew Meyerson published a 2007 paper detailing a method for large-panel testing of 238 DNA mutations. [4] Foundation Medicine launched in 2010 with a $25 million Series A financing led by Third Rock ...
In December 2017, Michael Pellini, the former CEO and standing Chairman of Foundation Medicine joined S32 as a Managing Partner. [13] In early 2019, Section 32 announced that it had raised nearly $200M for a second fund. [14] In November 2019, Steve Kafka, joined Section 32 as a Managing Partner.
Foundation Medicine Prices Initial Public Offering of Common Stock CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced the pricing of its initial public offering of ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing.The company is headquartered in Cambridge, Massachusetts.
Science & Tech. Shopping. Sports
The Foundation also paid some employees from Soon-Shiong's companies, which is a potentially inappropriate use of charitable funds to cover unrelated business overhead. [ 27 ] The foundation contributed a quarter of a $12 million donation by Soon-Shiong-controlled organizations to the University of Utah to set up a gene mapping project.
Here's the story behind the biotech stock that could be the best way to profit from the discovery of the century: CRISPR-Cas9 gene editing.